Drug Type Prophylactic vaccine, mRNA vaccine |
Synonyms PACE-SARS-CoV-2 mRNA polyplexes(Yale University) |
Target |
Mechanism SARS-CoV-2 S protein inhibitors(Coronavirus spike glycoprotein inhibitors), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization Xanadu BioStartupYale University |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Preclinical | US | 16 Aug 2023 |